First Opinion Janet Midega New global data showing 1.27 million deaths a year reveal the urgent need to address antimicrobial resistance
First Opinion Natalie Ma My company is developing new antibiotics. My resistant infection showed me we need them now
First Opinion Sevahn Vorperian and Stephen Quake The PASTEUR Act can help win the war against superbugs
First Opinion David Hyun and Rachel Zetts Many hospitalized Covid-19 patients are given antibiotics. That’s a problem
Health Helen Branswell Patients with feared superbug shed large amounts of it from their skin, study says
Pharmalot Ed Silverman STAT Plus: Sales of antibiotics for food-producing animals dropped by nearly half in Europe over the past decade
Pharmalot Ed Silverman STAT Plus: Several big U.S. grocery chains are failing to stop antibiotic overuse in their meat supply chains
First Opinion Steven Roach FDA and USDA need to get on board with the CDC about reducing antibiotic use in raising animals for food
Pharmalot Ed Silverman STAT Plus: ‘Eye-opening’: The Covid-19 pandemic accelerated antimicrobial resistance across the U.S.
Pharmalot Ed Silverman STAT Plus: In a first-of-its-kind deal, major drugmaker licenses antibiotic production for low-income countries
Pharmalot Ed Silverman STAT Plus: U.K. readies a Netflix-style subscription payment model for badly needed antibiotics
Pharmalot Ed Silverman STAT Plus: Pharma’s ambitious new antibiotic venture fund makes its first investments
Pharmalot Ed Silverman STAT Plus: McDonald’s accused of dragging its feet on goal of reducing antibiotic use in beef supplies
Pharmalot Ed Silverman STAT Plus: A lack of access: Pharma is failing to ensure new antibiotics will be available to poor countries, analysis finds
First Opinion Podcast Patrick Skerrett Listen: An antibiotic expert on her body’s stinging betrayal by these drugs
Pharmalot Ed Silverman Older Americans bore the brunt of antibiotic-resistant infections, study finds
In the Lab Peter Andrey Smith In the hunt for novel antibiotics, will new technology overtake underwater exploration?
Pharma Ed Silverman STAT Plus: STAT+ Conversations: the revitalization of the antibiotic drug pipeline
Pharma Ed Silverman STAT Plus: Drug-resistant bacteria pose a growing threat. Can new antibiotics be developed fast enough to combat them?
Pharmalot Ed Silverman STAT Plus: Lawmakers revive legislation to accelerate the development of new antibiotics
Pharmalot Ed Silverman STAT Plus: WHO warns the world is still failing to develop desperately needed antibiotics
First Opinion Podcast Patrick Skerrett Listen: Antibiotic experts on the threat of antimicrobial resistant superbugs
Pharmalot Ed Silverman STAT Plus: EPA rule that could help citrus growers is challenged over concerns about antibiotic resistance
Pharmalot Ed Silverman STAT Plus: Antibiotic stewardship may be improving at U.S. hospitals, but new targets are still needed
Pharmalot Ed Silverman STAT Plus: Antibiotic prescribing during the pandemic raises concern about drug resistance
First Opinion Michelle McMurry-Heath STAT Plus: The Biden administration’s pandemic agenda must not ignore superbugs
Politics Matthew Herper STAT Plus: Sen. Cassidy explains why he’s backing a bill aimed at drug-resistant bacteria